Research Topic · Peer-Reviewed

Sars-CoV-2

SARS-CoV-2 is the positive-sense single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19), the illness behind the global pandemic that began in late 2019. A member of the family Coronaviridae, it is structurally similar to the severe acute respiratory syndrome (SARS) coronavirus, from which it takes…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 13× across the literature 🔖 ISSN 2693-1176 🗓 Reviewed June 2026

Overview

SARS-CoV-2 is the positive-sense single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19), the illness behind the global pandemic that began in late 2019. A member of the family Coronaviridae, it is structurally similar to the severe acute respiratory syndrome (SARS) coronavirus, from which it takes its name, and it spreads primarily through respiratory droplets and aerosols. As the cause of a worldwide health crisis affecting populations across every region, SARS-CoV-2 has been a central subject of virological, clinical, and epidemiological research. From a global-health perspective, study of the virus encompasses its molecular evolution and the analysis of its spike glycoprotein gene, the detection and screening of variants of concern using rapid antigen and molecular methods, and viral kinetics under candidate treatments. Research published under this topic also examines host immune and cytokine responses to the spike protein, neutralizing antibodies in convalescent plasma, prediction of viral mutations, and mathematical modelling of transmissibility across interacting populations. Further work addresses clinical outcomes and mortality in higher-risk groups such as patients with cancer and diabetes, and the perceptions and roles of health-care professionals, including questions around transplantation in COVID-19 care, reflecting the intersection of laboratory science and population health that defines the topic.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2020

SARS-CoV-2 affected cells Pathogeny and Therapy

M.R PonizovskiyCorresponding author
Kiev, Ukraine, “Kiev regional p/n hospital”, /Head of “Laboratory Biochemistry and Toxicology”
Exact topic International Journal of Coronaviruses doi:10.14302/issn.2692-1537.ijcv-20-3538

How this research is being cited

The 12 articles above have been cited 13 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Sars-CoV-2, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in International Journal of Global Health (ISSN 2693-1176).

Journal editorial board
Andrew Hall · United Kingdom Richard Bright · Australia Zhiqiang Feng · United Kingdom

This page summarises published research for orientation; it is not medical or professional advice.